Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroendocrine Tumors × tremelimumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Carcinoma, Non-Small-Cell Lung 5 Liver Neoplasms 4 Small Cell Lung Carcinoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Seminoma 1 Pancreatic Neoplasms 1 Nonseminomatous germ cell tumor 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms, Germ Cell and Embryonal 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma 1 Lung Cancer Metastatic 1 Liver Cirrhosis 1 Hydronephrosis 1 Germinoma 1 Fallopian Tube Neoplasms 1 Dysgerminoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Adenocarcinoma, Follicular 1 Adenocarcinoma Of Esophagus 1

Interventions

lutetium Lu 177 dotatate 8 Magnetic Resonance Spectroscopy 8 Specimen Handling 7 Everolimus 5 pembrolizumab 4 lenvatinib 2 gallium Ga 68 dotatate 2 cabozantinib 2 X-Rays 2 Phantoms, Imaging 2 Octreotide 2 Nivolumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 Etoposide 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 2 tivozanib 1 peposertib 1 pazopanib 1 lanreotide 1 guarana powder 1 gadoteridol 1 gadoterate meglumine 1 gadolinium ethoxybenzyl DTPA 1 gadodiamide 1 gadobutrol 1 gadobenic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡